We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amag Complete Response Letter Cites Preapproval Inspection
Amag Complete Response Letter Cites Preapproval Inspection
January 13, 2009
The FDA issued a second complete response letter for Amag Pharmaceuticals’ anemia drug ferumoxytol, citing deficiencies investigators observed during a preapproval inspection of the company’s manufacturing facility.